Factory to foxhole. Mud to Moon. Palantir is the Operating System of Reindustrialization. Join us in Detroit @reindsummit to see how Palantir is giving American workers and warfighters an unfair advantage.

MAFIA EP 002

Introducing @PoeticHQ: a new AI system that executes complex multi-hour tasks with 99% accuracy and 10x fewer tokens than agents. We raised $50M at $500M from Kleiner Perkins, Founders Fund, First Harmonic, and Genius Ventures to build AI that does complex work inside Fortune 500 companies without hallucination. While code is too brittle, agents are too unpredictable. The work that runs the global economy - anti-money laundering, fraud investigations, underwriting - needs extreme accuracy. So we built a new kind of software that pairs the flexibility of AI with the predictability of code. When the world stays the same, Poetic runs fixed code: fast, cheap, identical every time. When the world changes, Poetic uses AI to regenerate its approach and find its way back to the objective. In one year, we went from zero to an eight-figure run rate as a team of four. Since then, we’ve scaled the team and executed the highest-stakes processes at AIG, SoFi, and Chime. At SoFi, a large US bank, Poetic reached 99% quality on fraud investigations in five weeks.

MAFIA EP 001

Many people don't understand the scale @SecWar is demanding. The United States has built less than 40,000 cruise missiles, ever, since the Army asked the Dayton-Wright Company to manufacture an Aerial Torpedo in 1917. The more time passes, the fewer we make and the more they cost. Leaders like DepSecWar Feinberg and @USWREMichael are actually responding to foreign threats and giving clear demand signal that is bringing billions of dollars of private capital into solving this problem. Now America will manufacture more cruise missiles in the next three years than the last 30 years combined, at a fraction of the cost. We are in the middle of hiring for Barracuda production at Arsenal-1 starting later this year, please hit us up if this mission is one you can be passionate about.

Varda believes humanity's first space-made product will be a pharmaceutical. Today we announced a research collaboration with United Therapeutics. Together we will explore the use of microgravity to develop improved formulations of medicines for rare pulmonary disease aboard Varda’s orbital platform. Small molecule drugs will fly to low Earth orbit, form novel crystals in microgravity, and come home via our W-series reentry capsule. Through this collaboration we will pioneer pharmaceutical processing in space, to benefit people on Earth.

We're announcing our $50M Series B led by Benchmark. Founders Fund and Human Capital are tripling down in the round. We gave Benchmark a sneak preview of our upcoming GA release. They saw the future of sales. We had a term sheet 2 hours later. The future of sales is Monaco.